LUNG SQUAMOUS CELL CARCINOMA
Clinical trials for LUNG SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough lung cancer
Disease control Not yet recruitingThis study tests a combination of two drugs, QL1706 and anlotinib, for people with advanced small cell lung cancer who have already tried at least two prior treatments. The goal is to see if the combination helps control the cancer and extends survival. About 120 adults aged 18 t…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can simulated High-Altitude breathing boost lung cancer treatment?
Disease control Not yet recruitingThis phase 2 trial tests whether adding intermittent hypoxic training (IHT) – short sessions of breathing low-oxygen air – to standard chemo-immunotherapy can improve outcomes for people with stage II-IIIA lung squamous cell carcinoma. About 60 participants will receive either st…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: zhang yi • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New immune drug takes on Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests a new drug called CRPA1A2, which helps the body's immune cells attack cancer cells. It is for people with certain advanced solid tumors (like lung, esophagus, head and neck, or liver cancer) that have not responded to other treatments. The study will …
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Corregene Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Blood test may predict who benefits from lung cancer combo therapy
Knowledge-focused Not yet recruitingThis study aims to see if changes in certain immune cells in the blood can predict how well advanced lung cancer patients respond to a combination of chemotherapy and immunotherapy. About 80 adults with stage IIIB or IV non-small cell lung cancer will give blood samples before an…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC